Can Target Keep Beating the Market?

Target Corporation (NYSE:TGT) is up 25% so far in 2012, beating the S&P 500’s gain. Investors believe that a continued weak recovery in the U.S. will keep driving consumers to discount retail stores. This explains the rise of not only Target and rival Wal-Mart Stores, Inc. (NYSE:WMT)- the Blue Team of the big-box discount retail industry is about even with Target’s performance this year- but also of the various dollar stores. Dollar General Corp. (NYSE:DG), for example, has seen its stock up about 25% this year as well.

Target Corporation’s sales edged up 3% in the second quarter of the year compared to the same period a year ago. This was a bit lower than what the company had experienced in the first quarter, bringing revenue growth for the first half of 2012 to 5%. Same store sales were 4% higher for the first six months of 2012 versus 2011. Net income ended up being about flat thanks to higher costs, but thanks to Target’s buyback program earnings per share for the first half of the year ended up at $2.10 compared to $2.02. Over $1 billion- nearly half of Target’s cash flow from operations- went to repurchasing shares in the first half of the year. This was actually less than the company spent in the comparable period in 2011, but that makes sense given the rise in the share price- would you not expect Target to be a smart shopper?- and it is still an impressive commitment to shareholder value.

David Shaw

Target now trades at 15 times trailing earnings, with forward earnings consensus for 2013 implying a P/E multiple of 13 for that period. Target Corporation, of course, is also notable as a decent way to play a bear market: its beta of 0.4 mean that it is not very exposed to broader market movements, and it pays a dividend yield of 2.3%. Growth has not been very good, with buybacks not pulling EPS up by enough by themselves to make the stock a good value, but we certainly don’t consider the stock overvalued at the current price.

D.E. Shaw increased its stake in Target by 13% during the second quarter of the year, and by the end of June the large hedge fund names after its founder and manager owned a total of 1.1 million shares of the company (see more stock picks from D.E. Shaw). Levin Capital Strategies, managed by John Levin, also liked the stock and increased its holdings of Target to 1.7 million shares, which came out to about $100 million (research more stocks Levin had $100 million invested in). Thomas Steyer’s Farallon Capital was another hedge fund with a large position in the stock, at 1.7 million shares as well.

Wal-Mart is narrowly more expensive than Target, at 16 times trailing earnings and 14 times forward estimates, but given its market leadership we think it deserves to trade at a premium relative to Target. Both retailers are also about even on a defensive basis, with Wal-Mart carrying a beta of 0.4 and a 2.1% dividend yield, so the two stocks end up looking about identical in terms of value proposition. Costco Wholesale Corporation (NASDAQ:COST) is the growth player in the big-box discount retail peer group: its earnings were up 19% last quarter compared to a year earlier, driven by an 8% increase in revenue and higher margins. However, it is priced for significant future growth at a forward P/E of 23. Target and Wal-Mart are cheaper enough that we would prefer them.

We’ve also mentioned Dollar General, and would also include Dollar Tree, Inc. (NASDAQ:DLTR) to give a better picture of this segment of the market. These stocks also trade at a premium relative to Target, as their trailing P/Es cluster in the 20-22 range and their forward P/Es are between 16 and 17. They don’t pay dividends, but they have betas of 0.1 and so might arguably be a better way to shield a portfolio from a market downturn. Dollar General and Dollar Tree also grew their respective earnings by 47% and 26% in their most recent quarter compared to the same period in the previous year; as such, they beat Costco on both value and growth. If investors believe that they can continue turning in higher earnings, they could be better buys than Target or Wal-Mart as well.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!